Cervical Intraepithelial Lesions: A Systematic Review
Revista Arbitrada Interdisciplinaria de Ciencias de la Salud. Salud y Vida · 15.05.2026 · 10 (2) · 4-26
DOI: 10.35381/s.v.v10i2.5081 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Revista Arbitrada Interdisciplinaria de Ciencias de la Salud. Salud y Vida, online erschienen am 15.05.2026. Verfasst von Adán Joél Villanueva-Sosa. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Cervical cancer remains a major cause of morbidity and mortality among women worldwide, particularly in low- and middle-income countries. This study aimed to systematically synthesise published evidence on the reported prevalence ranges of cervical cytological abnormalities—atypical. A systematic literature review was conducted in accordance with PRISMA guidelines. Higher proportions of abnormal cytology were consistently reported in resource-constrained settings with limited organised screening programmes. Strengthening organised screening programmes, improving cytotechnologist training, and enhancing follow-up systems are essential to reduce variability and disease burden. Limitations include heterogeneity in study designs and reporting standards, as well as exclusion of non-accessible publications.
Zitieren
APA
Villanueva-Sosa, A. J. (2026). Cervical Intraepithelial Lesions: A Systematic Review. Revista Arbitrada Interdisciplinaria de Ciencias de la Salud. Salud y Vida, 10(2), 4-26. https://doi.org/10.35381/s.v.v10i2.5081
Vancouver
Villanueva-Sosa AJ. Cervical Intraepithelial Lesions: A Systematic Review. Revista Arbitrada Interdisciplinaria de Ciencias de la Salud. Salud y Vida. 2026;10(2):4-26. doi:10.35381/s.v.v10i2.5081
BibTeX
@article{VillanuevaSosa2026,
author = {Villanueva-Sosa, Adán Joél},
title = {Cervical Intraepithelial Lesions: A Systematic Review},
journal = {Revista Arbitrada Interdisciplinaria de Ciencias de la Salud. Salud y Vida},
year = {2026},
volume = {10},
number = {2},
pages = {4--26},
doi = {10.35381/s.v.v10i2.5081}
}
EUVIMED